Mon.Sep 23, 2024

article thumbnail

The Green Beauty Community Becomes a Nonprofit

Pivot Point International

SAN DIEGO, CA—9/23/2024— The Green Beauty Community (GBC) is excited to announce its transformation into a nonprofit organization, amplifying its commitment to making sustainable beauty practices the industry standard. GBC met with key industry leaders at America’s Beauty Show – including Pivot Point International, Innersense Organic Beauty, Oway, Insight Professional, and Green Circle Salons – to discuss how to best support industry sustainability, leading to the decision to transition G

article thumbnail

Meet the New Ultherapy PRIME Platform From Merz Aesthetics

The Dermatology Digest

Merz Aesthetics is rolling out Ultherapy PRIME, a next-generation platform for Ultherapy. The platform’s operating system deliver 20% faster treatments, elevated ergonomics, and more efficient workflows for aesthetic health care professionals. Ultherapy PRIME’s 35% larger screen and faster image refresh rate provide better images from all angles, the Company reports.

article thumbnail

How Managing Comorbidities Can Transform Alopecia Areata Treatment Outcomes

Dermatology Times

Understanding comorbidities such as thyroid dysfunction and vitiligo helps to navigate comprehensive care to achieve long-lasting results in alopecia areata treatment.

article thumbnail

GlossGenius Debuts Product Innovations for Happier Clients and Staff

Salon Today

GlossGenius has announced new innovative Teams features, bridging the gap and challenging the notion that businesses must choose between delighting clients and empowering staff.

article thumbnail

Spooky Suite is Back!

My Salon Suite

The most spine-tingling time of the year is upon us, and we are beyond thrilled to announce the return of our highly anticipated Annual Spooky Suite Contest! This year, we’re spicing things up again with five electrifying categories, giving you even more ways to showcase your extraordinary talent and creativity. As we enter this season of thrills and chills, we can hardly wait to see the sensational, spooky, and spectacular transformations that you have in store for us.

Makeup 54
article thumbnail

FDA Approves UCB's Bimekizumab-bkzx for Psoriatic Arthritis

Dermatology Times

Bimzelx was also approved for non-radiographic axial spondyloarthritis and ankylosing spondylitis.

73

More Trending

article thumbnail

Diversifying Psoriasis Research to Benefit the Population

Dermatology Times

Zelma Chiesa Fuxench, MD, MSCE, FAAD, discusses the lack of research into psoriasis in skin of color, the absence of diversity in clinical trial populations, and where dermatology as a discipline can go from here.

Clinic 41
article thumbnail

Effective Treatments for Under Eye Darkness and Crepey Skin

US Dermatologt Partners

If dark circles and crepey skin around the eyes have you feeling less confident in your appearance, the good news is dermatologists can help you turn back the clock. According to Dr. Jennifer Sawaya of U.S. Dermatology Partners Scottsdale, “Age takes its toll on all areas of skin, but those areas that thinner tend to show age more quickly. That is especially evident in the skin around the eyes.

article thumbnail

Diagnostic Challenges in the Management of Pediatric Plaque Psoriasis

Dermatology Times

Karan Lal, DO, and Helen T Shin, MD, discuss how diagnostic challenges in pediatric plaque psoriasis, such as its similarity to other skin conditions and potential underreporting, can complicate timely identification and appropriate management of the disease in children.

article thumbnail

E.C. Approves Leo’s Delgocitinib Cream (Anzupgo) for CHE; FDA Accepts New Drug Application for Delgocitinib Cream in CHE

The Dermatology Digest

The European Commission (E.C.) has given its official nod to delgocitinib (Anzupgo, Leo Pharma) cream for adults with moderate to severe chronic hand eczema (CHE). In addition, the U.S. Food and Drug Administration has accepted LEO Pharma’s filing of a new drug application for delgocitinib cream in CHE. Delgocitinib, a topical pan-Janus kinase (JAK) inhibitor, is the first topical treatment to be specifically indicated for adult patients living with moderate to severe CHE across the European Uni

Safety 36
article thumbnail

GlossGenius Debuts Product Innovations for Happier Clients and Staff

Beauty Launchpad

New feature innovations from GlossGenius end the era of compromise, powering stronger relationships between business owners, clients and staff.

article thumbnail

Case-Based Discussion on Adherence, Adjunctive Therapy, and Simplifying Complex Regimens for Patients With Vitiligo

Dermatology Times

Panelists discuss how to improve treatment adherence, incorporate adjunctive therapies, and simplify complex regimens for patients with vitiligo through case-based analysis.

Therapy 36
article thumbnail

Integrative Health Comes To Body+Beauty Lab

Body + Beauty Lab

Optimize Your Health, Energy + Your Life. Join Our Wait List.

52
article thumbnail

Two Major Regulatory Milestones Announced for Delgocitinib for CHE

Dermatology Times

Announcements from both the FDA and the EC were supported by 2 clinical trials that evaluated the safety and efficacy of delgocitinib cream.

Safety 41
article thumbnail

Vitiligo Insights: Case-Based Discussion on Delayed Treatment, Psychosocial Impact, and Evolving Approaches for SOC Patients

Dermatology Times

Panelists discuss how vitiligo treatment delays, psychosocial effects, and emerging therapies impact standard of care for patients through case-based analysis.

article thumbnail

Skin Signs of Hereditary Angioedema

Dermatology Times

Review cutaneous signs and symptoms of HAE that may enhance early diagnosis and treatment.

article thumbnail

Navigating Treatment Algorithms: Balancing Provider Preferences and Clinical Guidelines

Dermatology Times

Panelists discuss how managing psoriasis in children poses distinct challenges compared to adult patients.

Clinic 36